These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cutaneous melanoma in a patient with neurofibromatosis: a case report and review of the literature. Duve S; Rakoski J Br J Dermatol; 1994 Aug; 131(2):290-4. PubMed ID: 7917998 [TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation. Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585 [TBL] [Abstract][Full Text] [Related]
5. Eye and hair colour, skin type and constitutive skin pigmentation as risk factors for basal cell carcinoma and cutaneous malignant melanoma. A Danish case-control study. Lock-Andersen J; Drzewiecki KT; Wulf HC Acta Derm Venereol; 1999 Jan; 79(1):74-80. PubMed ID: 10086866 [TBL] [Abstract][Full Text] [Related]
6. Late recurrence (beyond ten years) of cutaneous malignant melanoma. Report of two cases and a review of the literature. Koh HK; Sober AJ; Fitzpatrick TB JAMA; 1984 Apr; 251(14):1859-62. PubMed ID: 6700088 [TBL] [Abstract][Full Text] [Related]
15. Prevention of primary cutaneous malignant melanoma: increasing cure rate in the 1990's. Roy MA; Wagner RF Cutis; 1992 Nov; 50(5):365-70. PubMed ID: 1468259 [TBL] [Abstract][Full Text] [Related]
16. Cutaneous metastases of malignant melanoma: a clinicopathologic study of 192 cases with emphasis on the morphologic spectrum. Plaza JA; Torres-Cabala C; Evans H; Diwan HA; Suster S; Prieto VG Am J Dermatopathol; 2010 Apr; 32(2):129-36. PubMed ID: 20010406 [TBL] [Abstract][Full Text] [Related]